- Home
- ONCY vs LIDR Comparison
ONCY vs LIDR Comparison
Compare ONCY & LIDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCY
- LIDR
- Stock Information
- Founded
- ONCY 1998
- LIDR 2013
- Country
- ONCY Canada
- LIDR United States
- Employees
- ONCY N/A
- LIDR N/A
- Industry
- ONCY Pharmaceuticals and Biotechnology
- LIDR Auto Parts:O.E.M.
- Sector
- ONCY Health Care
- LIDR Consumer Discretionary
- Exchange
- ONCY Nasdaq
- LIDR Nasdaq
- Market Cap
- ONCY 89.7M
- LIDR 105.4M
- IPO Year
- ONCY 1999
- LIDR N/A
- Fundamental
- Price
- ONCY $1.11
- LIDR $2.41
- Analyst Decision
- ONCY Strong Buy
- LIDR Strong Buy
- Analyst Count
- ONCY 5
- LIDR 1
- Target Price
- ONCY $5.00
- LIDR $6.00
- AVG Volume (30 Days)
- ONCY 900.3K
- LIDR 5.6M
- Earning Date
- ONCY 11-07-2025
- LIDR 11-06-2025
- Dividend Yield
- ONCY N/A
- LIDR N/A
- EPS Growth
- ONCY N/A
- LIDR N/A
- EPS
- ONCY N/A
- LIDR N/A
- Revenue
- ONCY N/A
- LIDR $236,000.00
- Revenue This Year
- ONCY N/A
- LIDR $1.50
- Revenue Next Year
- ONCY N/A
- LIDR $2,806.06
- P/E Ratio
- ONCY N/A
- LIDR N/A
- Revenue Growth
- ONCY N/A
- LIDR N/A
- 52 Week Low
- ONCY $0.33
- LIDR $0.49
- 52 Week High
- ONCY $1.51
- LIDR $6.44
- Technical
- Relative Strength Index (RSI)
- ONCY 40.09
- LIDR 40.59
- Support Level
- ONCY $1.16
- LIDR $2.51
- Resistance Level
- ONCY $1.32
- LIDR $2.69
- Average True Range (ATR)
- ONCY 0.07
- LIDR 0.24
- MACD
- ONCY -0.01
- LIDR -0.05
- Stochastic Oscillator
- ONCY 12.46
- LIDR 4.33
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.
About LIDR AEye Inc.
AEye Inc is a provider of high-performance, active lidar systems for vehicle autonomy, driver-assistance systems (ADAS), and robotic vision applications. The company's software-definable 4Sight Intelligent Sensing Platform combines solid-state active lidar, an optionally fused low-light HD camera, and integrated deterministic artificial intelligence to capture more intelligent information with less data, enabling faster, more accurate, and more reliable perception of the surroundings. Majority of the Company's revenue is generated from customers located in the United States followed by Europe, and Asia-Pacific.